TerrAscend Corp. (TSX:TSND)
Canada · Delayed Price · Currency is CAD | Market Cap | 289.44M +80.1% |
| Revenue (ttm) | 365.43M -0.5% |
| Net Income | -114.07M |
| EPS | -0.37 |
| Shares Out | 309.56M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 24,650 |
| Open | 0.9400 |
| Previous Close | 0.9500 |
| Day's Range | 0.9250 - 0.9800 |
| 52-Week Range | 0.3250 - 2.0000 |
| Beta | 2.03 |
| Analysts | Strong Buy |
| Price Target | 1.80 (+92.51%) |
| Earnings Date | Aug 6, 2026 |
About TerrAscend
TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries under the Apothecarium brand name. It serves medical patients and adult-use consumers in North America. The company was incorporated in 2017 and is headqu... [Read more]
Full Company ProfileFinancial Performance
In 2025, TerrAscend's revenue was $260.56 million, a decrease of -2.81% compared to the previous year's $268.08 million. Losses were -$86.23 million, 7.47% more than in 2024.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for TSND stock is "Strong Buy." The 12-month stock price target is $1.80, which is an increase of 92.51% from the latest price.
News
TerrAscend Announces Results of Annual General Meeting
TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis operator, today announced the results of its a...
TerrAscend Transcript: AGM 2026
The meeting addressed director elections, auditor ratification, and approvals for stock option and RSU plans, all of which passed with shareholder approval. Voting was conducted online, and results will be announced via press release and Form 8-K.
TerrAscend Schedules Special Meeting of Shareholders in Preparation for U.S. Stock Exchange Uplisting
Special meeting will allow shareholders to vote on share consolidation to support potential uplisting to a U.S. stock exchange Special meeting will allow shareholders to vote on share consolidation to...
TerrAscend Slides: Investor presentation
TerrAscend has posted slides in relation to its latest quarterly earnings report, which was published on May 8, 2026.
TerrAscend Earnings Call Transcript: Q1 2026
Revenue reached $65.5M in Q1 2026 with strong gross and EBITDA margins, driven by operational efficiencies and growth in core Northeast markets. Regulatory changes, including medical cannabis rescheduling, are expected to further boost profitability and strategic flexibility.
TerrAscend Earnings release: Q1 2026
TerrAscend released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
TerrAscend Slides: Q1 2026
TerrAscend has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
TerrAscend Reports First Quarter 2026 Financial Results
Net Revenue of $65.5 million and Gross Profit Margin of 52.8% for Q1 2026 Q1 2026 Net Cash Provided from Continuing Operations of $8.7 million, representing 13.3% Operating Cash Flow Yield 1 Q1 2026 F...
TerrAscend Slides: Investor presentation
TerrAscend has posted slides in relation to its latest quarterly earnings report, which was published on April 28, 2026.
TerrAscend Announces Preliminary First Quarter 2026 Financial Results and Schedules Earnings Conference Call
First Quarter 2026 Net Revenue Totaled $65.5 million with Gross Profit Margin of 52.8% First Quarter 2026 Net Revenue Totaled $65.5 million with Gross Profit Margin of 52.8%
TerrAscend Earnings Call Transcript: Q4 2025
Q4 and full year 2025 saw strong margins, positive cash flow, and stable Adjusted EBITDA despite revenue headwinds. Expanded in New Jersey and Ohio, exited Michigan, and maintained disciplined M&A and capital allocation. Gross margins exceeded 52% for the year.
TerrAscend Earnings release: Q4 2025
TerrAscend released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
TerrAscend Slides: Q4 2025
TerrAscend has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
TerrAscend Reports Fourth Quarter and Full Year 2025 Financial Results
Net Revenue of $66.1 million for Q4 2025 and $260.6 Million for FY 2025 Gross Profit Margin of 52.1% for Q4 2025 and 52.3% for FY 2025 from continuing operations Q4 2025 Net Cash provided from contin...
TerrAscend closes Union Chill dispensary transaction
TerrAscend (TSNDF) announced that its consolidated entities closed on the previously announced transaction with Union Chill Cannabis Company, a high-performing dispensary in Hunterdon County. The tran...
TerrAscend Increases Retail Footprint in New Jersey with Closing of Union Chill Dispensary Transaction
Expands New Jersey retail footprint to four dispensaries Dispensary generates over $11 million in annualized revenue and is expected to be immediately accretive to EBITDA and cashflow Transaction fur...
TerrAscend, Mike Tyson partner to launch Tyson 2.0 in Maryland, Pennsylvania
TerrAscend (TSNDF) announced an exclusive licensing agreement with Tyson 2.0 to launch its products across Maryland and Pennsylvania. In Maryland, TerrAscend will manufacture and distribute premium fl...
Mike Tyson and TerrAscend Team Up To Launch Tyson 2.0 In Maryland And Pennsylvania
TORONTO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced an exclusive licensin...
TerrAscend Earnings Call Transcript: Q3 2025
Q3 2025 revenue was $65.1M, flat year-over-year, with improved gross and EBITDA margins and continued positive cash flow. Strategic exits and M&A, especially in New Jersey, are driving future growth, while the company remains well-positioned for regulatory changes and expansion.
TerrAscend Earnings release: Q3 2025
TerrAscend released its Q3 2025 earnings on November 6, 2025, summarizing the period's financial results.
TerrAscend Slides: Q3 2025
TerrAscend has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 6, 2025.
TerrAscend reports Q3 EPS (4c) vs. (6c) last year
Reports Q3 revenue $65.1M vs. $65.2M last year. “I’m pleased to report that both gross margins and Adjusted EBITDA margins improved meaningfully in the third quarter of 2025, marking another…
TerrAscend Reports Third Quarter 2025 Financial Results
Net Revenue of $65.1 million Gross Profit Margin of 52.1% from continuing operations, up 110 basis points from 51.0% in the third quarter of 2024 Net Cash provided from continuing operations of $7.1 ...
TerrAscend reschedules Q3 earnings conference call
TerrAscend (TSNDF) has rescheduled its November 6, 2025 earnings conference call to discuss the results for the third quarter ended September 30, 2025. The call will still be held on…
3 Marijuana Stocks To Start Your Cannabis Investing Journey
When searching for the best marijuana stocks to buy, here are the key factors most investors consider beforehand. To begin, educate yourself on the industry, including which companies are publicly tra...